IRMD
Iradimed Corp
NASDAQ · Health Care
$95.97
+1.43 (+1.51%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 72.88M | 60.46M | 365.45M | 371.28M | 367.15M |
| Net Income | 19.14M | 14.29M | 69.19M | 73.06M | 68.53M |
| EPS | — | — | — | — | — |
| Profit Margin | 26.3% | 25.0% | 18.9% | 19.7% | 18.7% |
| Rev Growth | +20.6% | +20.6% | +8.6% | +3.1% | +13.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 184.28M | 192.97M | 209.74M |
| Total Equity | — | — | 846.15M | 936.02M | 858.01M |
| D/E Ratio | — | — | 0.22 | 0.21 | 0.24 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 22.83M | 17.99M | 126.55M | 107.10M | 104.64M |
| Free Cash Flow | — | — | 41.49M | 59.94M | 58.81M |